Outcomes of Massive Rotator Cuff Tendon Tear Treatment.

Sponsor
Tartu University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06016439
Collaborator
University of Tartu (Other)
80
4
123

Study Details

Study Description

Brief Summary

Rotator cuff tear is the leading cause of shoulder pain in the elderly. There isn't enough evidence nor clinical guidelines to guide the treatment of massive rotator cuff tears, specially irreparable tears. Arthroscopic partial repair has been widely used and superior capsular reconstruction (SCR), either with allograft, autograft or augmentation with long head biceps brachii tendon (LHBBT), has been recently added. It is showing promising results, but lacking high quality evidence.

This is a prospective clinical study to compare the outcomes of different surgical methods for massive rotator cuff tendon tears. Minimal follow-up time will be two years. In this trial, massive rotator cuff tears will be anatomically repaired if possible. For irreparable tears a method will be randomly assigned intra-operatively once a tear is determined to be irreparable - either partial repair or partial repair with superior capsular reconstruction using the long head biceps brachii (LHBB) tendon. Patients who are eligible for the study but refuse operative treatment, will serve as conservative study group.

The hypothesis is that massive rotator cuff tears that are reparable will have the best functional outcomes. For irreparable tears, augmentation with LHBBT will give superior results over partial repair.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Arthroscopic rotator cuff partial repair with superior capsular augmentation with LHBBT
  • Procedure: Arthroscopic rotator cuff partial repair
  • Procedure: Arthroscopic complete rotator cuff repair
  • Device: Suture anchor(s)
N/A

Detailed Description

Patients with massive rotator cuff tendon tears aged between 50 to 80 years will be included in the study following the eligibility criteria. Massive tear is defined as grade III tear according to Davidson and Burkhart classification (2010), supraspinatus (SSP) tendon retraction described by Patte (1990) classification.

The study is conducted in Tartu University Hospital Sports Traumatology Centre and rotator cuff repair procedures will be done by three orthopaedic surgeons with long experience in arthroscopic shoulder surgery.

It is determined intra-operatively whether the tear is reparable or not. If possible, the tendon(s) will be anatomically repaired. For irreparable tears intra-operative urn randomization takes place - either partial repair or partial repair with SCR using the LHBB tendon. Surgical techniques will be standardized. Patients who refuse operative treatment, will be followed as conservative treatment group.

The primary objective of the study is the functional status of the included subjects in different treatment groups. The secondary objective of the study is to confirm whether the tendons are intact on follow-up magnetic resonance imaging (MRI) 6 months, 12 months and 24 months after operation using Sugaya classification (2007).

The post-operative therapy regimen will be the same for each study group. Subjects will come for scheduled visits at 6-month, 12-month, and 24-month timepoints. Assessment tools consist of range of motion (ROM), strength measurements, preoperative radiography measuring acromio-humeral index (AHI), critical shoulder angle (CSA), acromion type and shoulder arthrosis (Hamada), functional scores: The Disabilities of the Arm, Shoulder and Hand (DASH), The Constant-Murley score (CMS), The American Shoulder and Elbow Surgeons (ASES) and visual analogue scale (VAS), also including Tampa kinesiophobia score and emotional well-being (EEK) score. Goutallier classification (1994) will be used pre- and postoperatively to measure muscle fatty infiltration.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Outcomes of Different Treatment Modalities for Massive Rotator Cuff Tendon Tear.
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2033
Anticipated Study Completion Date :
Dec 1, 2033

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arthroscopic rotator cuff partial repair with superior capsule augmentation with LHBBT

If a tear is intra-operatively determined irreparable, randomization takes place. Irreparable tears that are randomly selected to receive arthroscopic rotator cuff partial repair including superior capsular augmentation with proximal part of the long head of the biceps tendon. The long head of the biceps tendon will be released from bicipital groove and proximal part of the tendon will be used to cover the rotator cuff gap and anchored to the greater tuberosity.

Procedure: Arthroscopic rotator cuff partial repair with superior capsular augmentation with LHBBT
Residual rotator cuff defect will be reconstructed using LHBBT.

Device: Suture anchor(s)
Arthroscopic rotator cuff tendon(s) repair using suture anchor(s).

Active Comparator: Arthroscopic partial rotator cuff repair

If a tear is intra-operatively determined irreparable, randomization takes place. Irreparable tears that are randomly selected to receive arthroscopic partial repair.

Procedure: Arthroscopic rotator cuff partial repair
Rotator cuff will be repaired with remaining residual defect.

Device: Suture anchor(s)
Arthroscopic rotator cuff tendon(s) repair using suture anchor(s).

Other: Arthroscopic rotator cuff repair

Arthroscopic complete repair.

Procedure: Arthroscopic complete rotator cuff repair
Arthroscopic complete repair as a standard procedure.

Device: Suture anchor(s)
Arthroscopic rotator cuff tendon(s) repair using suture anchor(s).

No Intervention: Rotator cuff tear conservative treatment

Conservative treatment following physiotherapy protocol.

Outcome Measures

Primary Outcome Measures

  1. Change in shoulder strength [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Measured by the change in rotator cuff strength isokinetic testing (abduction, internal and external rotation).

  2. Change in shoulder range of motion. [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Measured by the change in shoulder range of motion (abduction, internal and external rotation).

  3. Functional outcome according to the American Shoulder and Elbow Surgeons (ASES) score. [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Measured by the change in joint functional score. The higher the score, the better the outcome. The patient self-assessment (pASES) includes 6 pain items and 10 functional items that are shoulder specific (Angst, 2008). The pASES form has 3 sections: pain, instability, activities of daily living (ADLs) (Goldhahn, 2008). Pain section: 4 questions with yes/no responses, 1 question covering number of pain tablets per day, and a VAS (visual analogue scale) from 0 (no pain) to 10 (worst pain). Instability section: 2 questions (1. Response yes/no about feelings of instability, 2. Quantify instability from 0 (stable) to 10 (very unstable)). Activities of daily living (ADLs): Each shoulder is included (affected/non affected), 10 items, with a 4 point ordinal scale, range: 0 (unable to perform activity) to 3 (no difficulty in doing activity) (Goldhahn 2008).

  4. Functional outcome according to the Constant-Murley score (CMS). [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Measured by the change in joint functional score. The higher the score, the higher the quality of the function. The test is divided into four subscales: pain (15 points), activities of daily living (ADL) (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points).

  5. Functional outcome according to the Disabilities of the Arm, Shoulder and Hand (DASH). [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Measured by the change in joint functional score. The higher the score, the more severe disability. 30-item self-report questionnaire designed to assess symptoms and function of the entire upper extremity. Total scores range from 0 (minimum) to (100) maximum.

  6. Change in pain score [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Measured by the change in pain score according to the visual analogue scale (VAS) from 0 (no pain) to 10 (worst pain).

Secondary Outcome Measures

  1. Integrity of surgically repaired rotator cuff tendons on MRI studies using Sugaya classification (2005). [postoperatively 6 months, 12 months and 24 months]

    Integrity of surgically repaired rotator cuff tendons on post-operative MRI studies. Classified into five categories (from intact tendon to full tear): Type I: sufficient thickness with homogeneously low intensity; Type II: sufficient thickness with partial high intensity; Type III: insufficient thickness without discontinuity; Type IV: the presence of a minor discontinuity; Type V: the presence of a major discontinuity.

  2. Change in quality of life [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Measured by the change in score according to EEK-2 (emotsionaalse enesetunde küsimustik, Emotional State Questionnaire) score. The higher the score, the higher the risk of having emotional state disabilities. The overall score ranges from 0-112, but it is divided into six categories that are assessed separately.

  3. Change in kinesiophobia score [Pre-operative baseline, 6-months, 12-months and 24-months follow-up visit]

    Change in kinesiophobia score according to Tampa Scale for Kinesiophobia. The higher the score, the higher the degree of kinesiophobia. Results consist of a total raw score (range between 17 and 68) and two subscale scores (activity avoidance and somatic focus).

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Massive rotator cuff tendon tear: grade III according to Davidson and Burkhart 2010 classification, diagnosed on MRI, and LHBB tendon is intact.

  • Primary rotator cuff pathology AND

  • Symptoms have not lasted more than 6 months.

  • In case of trauma, traumatic event no more than 6 months ago.

  • Aged between 50 and 80 at the time of enrollment.

  • Subject is able and willing to give informed consent AND

  • Subject is physically and mentally willing and able to comply with the post-operative rehabilitation protocol, questionnaires, and scheduled clinical and radiographic visits.

Exclusion Criteria:
  • Previous rotator cuff surgery of the index shoulder.

  • Acute or chronic osteomyelitis.

  • Inflammatory joint disease (rheumatoid arthritis/ (pseudo)gout arthritis).

  • Uncontrolled diabetes.

  • Active oncological disease.

  • Radiologically stage IV shoulder joint arthrosis (rotator cuff arthropathy).

  • Systemic or intra-articular corticosteroid therapy less than 60 days prior to planned operation date.

  • Intramuscular or peroral corticosteroid treatment less than 30 days prior to planned operation date.

  • Acute or chronic conditions that are contraindications for functional testing.

  • MRI contraindicated.

  • Substance or alcohol abuse.

  • Refusal or withdrawal of consent.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Tartu University Hospital
  • University of Tartu

Investigators

  • Principal Investigator: Tiina Tikk, MD, Tartu University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tartu University Hospital
ClinicalTrials.gov Identifier:
NCT06016439
Other Study ID Numbers:
  • Tikk23
First Posted:
Aug 29, 2023
Last Update Posted:
Aug 29, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tartu University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 29, 2023